Industry Updates
- Novosound Awarded Patent for Ultrasonic Instrumentation System
- Ensuring Continued Availability of In-Vitro Diagnostics in UK, EU
- Medtronic’s Newest Generation Evolut FX+ System Nabs FDA Nod
- The Most Dangerous Medical Devices Ever to Hit the Market
- Neuronetics Nabs FDA Clearance for NeuroStar Treatment in Adolescents
- Shortages, Other COVID-19 Impacts to Affect Device Makers Into Next Year
- EU Expert Panels to Review High-Risk IVDs
- Australia’s TGA Sues Medtronic for Unlawful Supply of Bone Graft Kit
- FDA, ECRI Release First Reports on Safety of Materials Used in Implantable Devices
- Australia Reports Progress in Implementing Medical Device Reforms
- Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial) Due to Presence of White Particles
- Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, Due to the Potential for Some Bottles to be Super Potent Which May be Harmful
- 2023 Safety Communications
- Medline Industries Recalls Certain Kits and Trays Containing Sterile Water Based Products Under Recall by Nurse Assist
- 2024 Medical Device Recalls
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race
- Time to Eliminate Health Care Disparities in the Estimation of Kidney Function
- Uncomfortable Truths — What Covid-19 Has Revealed about Chronic-Disease Care in America
- The 2021 Reauthorization of CAPTA — Letting Public Health Lead
- Point-of-Care Ultrasonography